GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Portland Press Ltd. ; 2003
    In:  Biochemical Society Symposia Vol. 70 ( 2003-09-01), p. 201-212
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 201-212
    Abstract: The tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of the matrix metalloproteinases (MMPs), enzymes that play central roles in the degradation of extracellular matrix components. The balance between MMPs and TIMPs is important in the maintenance of tissues, and its disruption affects tissue homoeostasis. Four related TIMPs (TIMP-1 to TIMP-4) can each form a complex with MMPs in a 1:1 stoichiometry with high affinity, but their inhibitory activities towards different MMPs are not particularly selective. The three-dimensional structures of TIMP-MMP complexes reveal that TIMPs have an extended ridge structure that slots into the active site of MMPs. Mutation of three separate residues in the ridge, at positions 2, 4 and 68 in the amino acid sequence of the N-terminal inhibitory domain of TIMP-1 (N-TIMP-1), separately and in combination has produced N-TIMP-1 variants with higher binding affinity and specificity for individual MMPs. TIMP-3 is unique in that it inhibits not only MMPs, but also several ADAM (a disintegrin and metalloproteinase) and ADAMTS (ADAM with thrombospondin motifs) metalloproteinases. Inhibition of the latter groups of metalloproteinases, as exemplified with ADAMTS-4 (aggrecanase 1), requires additional structural elements in TIMP-3 that have not yet been identified. Knowledge of the structural basis of the inhibitory action of TIMPs will facilitate the design of selective TIMP variants for investigating the biological roles of specific MMPs and for developing therapeutic interventions for MMP-associated diseases.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Arthritis & Rheumatology, Wiley, Vol. 68, No. 5 ( 2016-05), p. 1165-1171
    Abstract: The pathogenesis of osteoarthritis (OA) is poorly understood. Loss of the proteoglycan aggrecan from cartilage is an early event. Recently, we identified a role for the JNK pathway, particularly JNK‐2, in human articular chondrocytes in vitro in regulating aggrecan degradation. The present study was undertaken to investigate whether JNK‐2 has a similar function in vivo and to examine its role in gene expression. Methods Aggrecan fragments were analyzed by Western blotting. OA was induced by destabilization of the medial meniscus (DMM) and assessed at 4, 8, and 12 weeks after surgery. Knee sections were stained with Safranin O. Medial compartments were scored by histologic grading for aggrecan loss and cartilage damage. RNA was extracted from JNK‐2 −/− and wild‐type mouse knees 6 hours after DMM or after interleukin‐1 stimulation of the proximal epiphysis, and expression of 33 DMM‐regulated genes was analyzed with quantitative polymerase chain reaction–customized array cards. Results In vitro, basal and interleukin‐1– or tumor necrosis factor–stimulated release of aggrecanase‐generated aggrecan fragments was greatly reduced in cartilage from JNK‐2 −/− mice. In the OA model, JNK‐2 −/− mice exhibited significant reduction of aggrecanase‐generated fragments and cartilage damage. Of 33 genes investigated, 13 were significantly down‐regulated in JNK‐2 −/− mice compared with wild‐type mice, following DMM. These included Has1 , Adamts4 , Tnf , Il6 , Il18 , Il18rap , Il1a , Inhba , Cd68 , Ngf , Ccr2 , Wnt16 , and Tnfaip6 , but not Adamts5 . Conclusion Our results demonstrate that JNK‐2 regulates aggrecan degradation in cultured murine cartilage and surgically induced OA in vivo following mechanical destabilization of the knee joint. This implicates the JNK signaling pathway in OA and suggests potential novel approaches to therapy.
    Type of Medium: Online Resource
    ISSN: 2326-5191 , 2326-5205
    URL: Issue
    RVK:
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2754614-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 81-94
    Abstract: The collagen-platelet interaction is central to haemostasis and may be a critical determinant of arterial thrombosis, where subendothelium is exposed after rupture of atherosclerotic plaque. Recent research has capitalized on the cloning of an important signalling receptor for collagen, glycoprotein VI, which is expressed only on platelets, and on the use of collagen-mimetic peptides as specific tools for both glycoprotein VI and integrin α2ϐ1. We have identified sequences, GPO and GFOGER (where O denotes hydroxyproline), within collagen that are recognized by the collagen receptors glycoprotein VI and integrin α2ϐ1 respectively, allowing their signalling properties and specific functional roles to be examined. Triple-helical peptides containing these sequences were used to show the signalling potential of integrin α2ϐ1, and to confirm its important contribution to platelet adhesion. Glycoprotein VI appears to operate functionally on the platelet surface as a dimer, which recognizes GPO motifs that are separated by four triplets of collagen sequence. These advances will allow the relationship between the structure of collagen and its haemostatic activity to be established.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Portland Press Ltd. ; 2003
    In:  Biochemical Society Symposia Vol. 70 ( 2003-09-01), p. 233-242
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 233-242
    Abstract: Caspase activation is the 'point of no return' commitment to cell death. Synthesized as inactive zymogens, it is essential that the caspases remain inactive until the death signal is received. It is known for the downstream executioner caspases-3 and -7 that the activation event is proteolytic cleavage, and this had been assumed to apply to the initiator caspases as well. However, recent studies conducted on caspases-2, -8 and -9 have challenged this tenet of caspase activation. In this review we focus on the molecular details of caspase activation, with emphasis on recent work that provides a pleasing explanation for the differential requirements for the activation of executioner and initiator caspases.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 31-38
    Abstract: The adaptive immune response depends on the creation of suitable peptides from foreign antigens for display on MHC molecules to T lymphocytes. Similarly, MHC-restricted display of peptides derived from self proteins results in the elimination of many potentially autoreactive T cells. Different proteolytic systems are used to generate the peptides that are displayed as T cell epitopes on class I compared with class II MHC molecules. In the case of class II MHC molecules, the proteases that reside within the endosome/lysosome system of antigen-presenting cells are responsible; surprisingly, however, there are relatively few data on which enzymes are involved. Recently we have asked whether proteolysis is required simply in a generic sense, or whether the action of particular enzymes is needed to generate specific class II MHC-associated T cell epitopes. Using the recently identified mammalian asparagine endopeptidase as an example, we review recent evidence that individual enzymes can make clear and non-redundant contributions to MHC-restricted peptide display.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Portland Press Ltd. ; 2003
    In:  Biochemical Society Symposia Vol. 70 ( 2003-09-01), p. 213-220
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 213-220
    Abstract: Mempasin 2, a ϐ-secretase, is the membrane-anchored aspartic protease that initiates the cleavage of amyloid precursor protein leading to the production of ϐ-amyloid and the onset of Alzheimer's disease. Thus memapsin 2 is a major therapeutic target for the development of inhibitor drugs for the disease. Many biochemical tools, such as the specificity and crystal structure, have been established and have led to the design of potent and relatively small transition-state inhibitors. Although developing a clinically viable mempasin 2 inhibitor remains challenging, progress to date renders hope that memapsin 2 inhibitors may ultimately be useful for therapeutic reduction of ϐ-amyloid.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Portland Press Ltd. ; 2003
    In:  Biochemical Society Symposia Vol. 70 ( 2003-09-01), p. 147-161
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 147-161
    Abstract: The effective management of AIDS with HIV protease inhibitors, or the use of angiotensin-converting enzyme inhibitors to treat hypertension, indicates that proteases do make good drug targets. On the other hand, matrix metalloproteinase (MMP) inhibitors from several companies have failed in both cancer and rheumatoid arthritis clinical trials. Mindful of the MMP inhibitor experience, this chapter explores how tractable proteases are as drug targets from a chemistry perspective. It examines the recent success of other classes of drug for the treatment of rheumatoid arthritis, and highlights the need to consider where putative targets lie on pathophysiological pathways--regardless of what kind of therapeutic entity would be required to target them. With genome research yielding many possible new drug targets, it explores the likelihood of discovering proteolytic enzymes that are causally responsible for disease processes and that might therefore make better targets, especially if they lead to the development of drugs that can be administered orally. It also considers the impact that biologics are having on drug discovery, and in particular whether biologically derived therapeutics such as antibodies are likely to significantly alter the way we view proteases as targets and the methods used to discover therapeutic inhibitors.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 135-146
    Abstract: Over the last few years, it has been clearly established that normal plasma contains low levels of oxidized polypeptides, and that these accumulate in tissues during several age-related pathologies. In contrast, normal mammalian aging, contrary to conventional dogma, is not clearly associated with enhanced levels of oxidized proteins, except in extracellular connective tissues, whose proteins can, for example, be oxidized by the neutrophil oxidative burst. Since mildly oxidized proteins are susceptible to accelerated degradation in most experimental systems, the question arises as to how the accumulation of oxidized proteins can take place. Such accumulation requires an excess of production (or deposition) over removal, which might reflect alterations in capacity or rate of production or removal. This chapter discusses our presently limited knowledge of rates and control of proteolysis of oxidized proteins in two pathologies, cataractogenesis and atherogenesis. It commences with a brief summary of current understanding of the mechanisms of protein oxidation, and of the observed accumulation of oxidized proteins in several pathologies.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 107-114
    Abstract: Degradation of the cartilage proteoglycan, aggrecan, is an essential aspect of normal growth and development, and of joint pathology. The roles of different proteolytic enzymes in this process can be determined from the sites of cleavage in the aggrecan core protein, which generates novel termini (neoepitopes). Antibodies specific for the different neoepitopes generated by such cleavage events provide powerful tools with which to analyse these processes. The same approach can be used to differentiate the processed, active forms of proteases from their inactive pro-forms. Since the proteolytic processing of these enzymes requires the removal of the inhibitory pro-region, it also results in the generation of N-terminal neoepitopes. Using the newborn rat long bone as a model system, it was shown that the active form of ADAMTS-4 [ADAM (a disintegrin and metalloproteinase) with thrombospondin motifs-4] , but not ADAMTS-5, co-localizes with the aggrecan cleavage neoepitopes known to be produced by this metalloproteinase. Thus, in long bone growth, aggrecan turnover seems to be dependent on ADAMTS-4 activity. To demonstrate the molecular basis of the specificity of anti-neoepitope antibodies, the Fv region of a monoclonal antibody specific for a neoepitope generated by the ADAMTS-4-mediated cleavage of aggrecan has been modelled and the binding of the peptide epitope simulated. In the docked structure, the N-terminus of the peptide antigen is clearly buried in the binding-site cavity. The absence of an open cleft makes it impossible for the intact substrate to pass through the binding site, providing a rationale for the specificity of this class of antibodies.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Biochemical Society Symposia, Portland Press Ltd., Vol. 70 ( 2003-09-01), p. 115-123
    Abstract: The development of cartilage pathology in osteoarthritis involves excessive damage to the collagen fibrillar network, which appears to be mediated primarily by the chondrocyte-generated cytokines interleukin-1 and tumour necrosis factor α and the collagenases matrix metalloproteinase-1 (MMP-1) and MMP-13. The damage to matrix caused by these and other MMPs can result in the production of sufficient degradation products that can themselves elicit further degradation, leading to chondrocyte differentiation and eventually matrix mineralization and cell death. Knowledge of these MMPs, cellular receptors and cytokine pathways, and the ability to selectively antagonize them by selective blockade of function, may provide valuable therapeutic opportunities in the treatment of osteoarthritis and other joint diseases involving cartilage resorption, such as rheumatoid arthritis. The ability to detect the products of these degradative events released into body fluids of patients may enable us to monitor disease activity, predict disease progression and determine more rapidly the efficacy of new therapeutic agents.
    Type of Medium: Online Resource
    ISSN: 0067-8694 , 1744-1439
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2003
    detail.hit.zdb_id: 597642-X
    detail.hit.zdb_id: 2189143-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...